Ep205: Heather Turner on a Schizophrenia Drug Patients Can Stick With

from The Long Run with Luke Timmerman · host Timmerman Report

Heather Turner, CEO of New York-based LB Pharma, on developing a new schizophrenia drug designed to better cross the blood-brain barrier, be dosed once daily, and make it easier for patients to take long term.

Episode metadata supplied by the publisher feed · Published Jul 14, 2026

Embed this episode

Attribution link and audio player

NOW PLAYING

Ep205: Heather Turner on a Schizophrenia Drug Patients Can Stick With

0:00 1:08:18

1×

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Share this episode

Similar Episodes

No similar episodes found.

Similar Podcasts

No similar podcasts found.

Frequently Asked Questions

How long is this episode of The Long Run with Luke Timmerman?

This episode is 1 hour and 8 minutes long.

When was this The Long Run with Luke Timmerman episode published?

This episode was published on July 14, 2026.

Can I download this The Long Run with Luke Timmerman episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.

URL copied to clipboard!